Control of Epidemic Influenza Through a School-based Influenza Vaccination Program

PHASE4CompletedINTERVENTIONAL
Enrollment

29,255

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

live attenuated and inactivated influenza vaccines

Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) were administered to eligible children through a research program to improve vaccination coverage in school-aged children. Children 4 years of age and older in the intervention cites (Temple, Belton, Academy, Troy, Salado, Rogers, and Holland) will be offered LAIV or IIV through a school-based research vaccination program. Children living in the comparison cities (Waco, Bryan and College Station) which are within 90 miles of the intervention cites received LAIV or IIV from the local healthcare providers

Trial Locations (2)

76508

Scott & White Hospital and Clinic, Temple

76710

Scott & White Hospital and Clinic, Waco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Scott and White Hospital & Clinic

OTHER

collaborator

Novartis

INDUSTRY

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Baylor College of Medicine

OTHER